David Peltier


David Peltier joined TheStreet as a research associate in August 2001, and writes TheStreet Stocks Under $10. Before that, Peltier was an analyst for Individual Investor magazine and the publication's Web site. His market interests include small-caps, technology and retail stocks. He has appeared on NPR, NBR and WNYW-TV.

Peltier received his bachelor's degree cum laude in finance and international business from New York University.




A Note From David: My name is David Peltier. I manage a much-followed portfolio for TheStreet called Stocks Under $10 -- the unique investment service that alerts you to what I believe are deeply undervalued stocks with tremendous growth potential.


I've made it my life's work to help investors like you build lasting wealth by investing in only the very best small company stocks.


Because it's these little-known companies, which are overlooked by much of Wall Street, that could break out and double or even triple your money!


Start Your 14-Day Free Trial of Stocks Under $10.


Recent Articles By The Author

Exiting This Portfolio Holding

We will sell our remaining shares of Ballantyne Strong and book a significant gain.

CVS, Abbott Labs Likely to Hike Dividends

Both companies have a track record of raising dividends in December.

Positive Clinical Trial Lifts TherapeuticsMD

Stock soars after hours.

Adding a Name to the Bullpen

Hudson Technologies piques our interest, plans public offering.

Steer Clear of Banc of California

It appears capable of supporting its newly raised dividend, but a delayed SEC filing and potential delisting are cause for concern.